Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
Would you omit post-lumpectomy radiotherapy for high clinical risk, but low molecular risk DCIS?
The patient had a high-grade DCIS with necrosis, but a 0.9 DCSionRT score
Answer from: Radiation Oncologist at Community Practice
For now, I have been only omitting/discussing omission if both, clinical path and molecular test are concordant.
Sign in or Register to read more
21306
Related Questions
Are there any accruing trials in the U.S. evaluating selective use of radiation after mastectomy in early stage breast cancer?
How do we reconcile what appears to be a more aggressive surgical resection for DCIS than for invasive disease?
Do you use traditional bony landmarks or contoured nodal volumes when designing breast and supraclavicular treatment fields?
Is a completion axillary dissection required for a patient with clinical N+ disease who had a complete clinical response in the axilla to neoadjuvant systemic therapy but is found to ypN+ disease on sentinel node biopsy?
Do you routinely perform mammograms for women that underwent nipple-sparing mastectomy with reconstruction after a breast cancer diagnosis?
Do you offer APBI to patients who do not have surgical clips but a visible seroma?
Do you offer APBI for patients with invasive disease if there is high grade DCIS present in the lumpectomy specimen?
What evidence supports the use of high tangents for pN1mic breast cancer?
Would you offer adjuvant radiotherapy to a young patient with microinvasive lobular carcinoma (< 1 mm) in a background of LCIS?
For women with non-autologous breast reconstruction who require PMRT, is it better to radiate an implant or an expander?